India’s Pharma Market to "Skyrocket to $55 Billion by 2020", Says Report
January 28, 2016.
The pharma market in India, valued at $20 billion in 2015, is set to soar to $55 billion by 2020, according to GlobalData.
India’s generics market will see sales grow by nearly 84% to $26.1 billion in 2016, says the GlobalData report.
Indian companies are "now exporting to countries like Brazil, Mexico, South Africa, Russia and Japan, and, according to India’s Ministry of Commerce and Industry, the nation’s pharmaceutical export segment has more than doubled from $7.8 billion in 2008 to $16.5 billion in 2014," said analyst Adam Dion, MSc.
The country's biosimilars market is also expected to increase to $40 billion globally by 2020.
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – India
Is Artificial Intelligence a ‘Product’? Products Liability Implications for AI-Based Products
April 10th 2025As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.
